Adicet Net Debt vs Total Liab Analysis

ACET Stock

USD 1.73 0.00 0.00%

Adicet Bio financial indicator trend analysis is way more than just evaluating Adicet Bio prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Adicet Bio is a good investment. Please check the relationship between Adicet Bio Net Debt and its Total Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adicet Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

For more information on how to buy Adicet Stock please use our How to Invest in Adicet Bio guide.

Net Debt vs Total Liab

Net Debt vs Total Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Adicet Bio Net Debt account and Total Liab. At this time, the significance of the direction appears to have weak relationship.

The correlation between Adicet Bio's Net Debt and Total Liab is 0.35. Overlapping area represents the amount of variation of Net Debt that can explain the historical movement of Total Liab in the same time period over historical financial statements of Adicet Bio, assuming nothing else is changed. The correlation between historical values of Adicet Bio's Net Debt and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Debt of Adicet Bio are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Net Debt i.e., Adicet Bio's Net Debt and Total Liab go up and down completely randomly.

Correlation Coefficient

0.35

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Most indicators from Adicet Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Adicet Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adicet Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

For more information on how to buy Adicet Stock please use our How to Invest in Adicet Bio guide.At this time, Adicet Bio's Selling General Administrative is comparatively stable compared to the past year. Tax Provision is likely to gain to 0.00 in 2024, despite the fact that Enterprise Value is likely to grow to (54.6 M).

	2023	2024 (projected)
Total Operating Expenses	126.5M	132.8M
Cost Of Revenue	6.1M	5.8M

Total Operating Expenses Cost Of Revenue

Adicet Bio fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Good Will	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Net Receivables	Non Currrent Assets Other
Total Assets		-0.13	0.88	0.81	0.41	0.1	-0.47	-0.16	0.49	0.72	0.14	0.93	-0.01	-0.09	0.32	-0.47	-0.27	0.39	0.13	0.04	0.76	0.96	-0.03	0.69	0.29	0.43
Short Long Term Debt Total	-0.13		-0.09	0.02	0.12	-0.46	-0.31	0.8	0.27	0.0	-0.26	0.01	-0.33	0.96	-0.59	-0.13	0.84	0.65	-0.12	-0.23	0.11	-0.22	0.94	0.0	0.82	-0.88
Other Current Liab	0.88	-0.09		0.95	0.69	-0.14	-0.56	0.11	0.62	0.88	-0.26	0.91	-0.4	-0.09	0.27	-0.35	-0.29	0.52	0.24	0.13	0.88	0.78	0.02	0.86	0.37	0.43
Total Current Liabilities	0.81	0.02	0.95		0.69	-0.34	-0.6	0.27	0.79	0.97	-0.39	0.86	-0.55	0.04	0.14	-0.38	-0.15	0.68	0.36	-0.07	0.9	0.7	0.14	0.96	0.51	0.32
Total Stockholder Equity	0.41	0.12	0.69	0.69		-0.38	-0.51	0.44	0.5	0.69	-0.64	0.53	-0.72	0.11	-0.02	-0.12	-0.1	0.59	0.31	0.46	0.59	0.29	0.24	0.7	0.5	0.09
Property Plant And Equipment Net	0.1	-0.46	-0.14	-0.34	-0.38		0.11	-0.82	-0.78	-0.43	0.79	-0.03	0.72	-0.44	0.61	-0.4	-0.35	-0.59	-0.32	0.5	-0.38	0.19	-0.44	-0.45	-0.56	0.27
Current Deferred Revenue	-0.47	-0.31	-0.56	-0.6	-0.51	0.11		-0.24	-0.41	-0.64	0.08	-0.43	0.31	-0.37	-0.3	0.63	0.06	-0.77	-0.3	-0.2	-0.37	-0.47	-0.49	-0.64	-0.63	0.24
Net Debt	-0.16	0.8	0.11	0.27	0.44	-0.82	-0.24		0.59	0.3	-0.77	0.08	-0.78	0.75	-0.68	0.14	0.67	0.72	0.07	-0.28	0.35	-0.31	0.77	0.31	0.78	-0.6
Retained Earnings	0.49	0.27	0.62	0.79	0.5	-0.78	-0.41	0.59		0.84	-0.59	0.57	-0.67	0.3	-0.32	-0.06	0.17	0.77	0.39	-0.52	0.75	0.38	0.35	0.85	0.65	0.03
Accounts Payable	0.72	0.0	0.88	0.97	0.69	-0.43	-0.64	0.3	0.84		-0.44	0.75	-0.6	0.03	0.12	-0.35	-0.18	0.71	0.51	-0.11	0.83	0.63	0.14	0.99	0.51	0.29
Cash	0.14	-0.26	-0.26	-0.39	-0.64	0.79	0.08	-0.77	-0.59	-0.44		-0.11	0.94	-0.2	0.5	-0.35	-0.2	-0.46	-0.22	0.09	-0.41	0.31	-0.26	-0.46	-0.39	0.07
Non Current Assets Total	0.93	0.01	0.91	0.86	0.53	-0.03	-0.43	0.08	0.57	0.75	-0.11		-0.27	0.03	0.14	-0.43	-0.07	0.48	-0.01	0.01	0.86	0.8	0.1	0.73	0.39	0.35
Cash And Short Term Investments	-0.01	-0.33	-0.4	-0.55	-0.72	0.72	0.31	-0.78	-0.67	-0.6	0.94	-0.27		-0.28	0.44	-0.02	-0.27	-0.64	-0.31	0.07	-0.53	0.17	-0.37	-0.63	-0.54	0.11
Good Will	-0.09	0.96	-0.09	0.04	0.11	-0.44	-0.37	0.75	0.3	0.03	-0.2	0.03	-0.28		-0.5	-0.14	0.83	0.7	-0.15	-0.24	0.03	-0.16	0.99	0.03	0.85	-0.91
Common Stock Shares Outstanding	0.32	-0.59	0.27	0.14	-0.02	0.61	-0.3	-0.68	-0.32	0.12	0.5	0.14	0.44	-0.5		-0.29	-0.72	-0.24	0.03	0.45	-0.09	0.42	-0.44	0.08	-0.39	0.44
Short Term Investments	-0.47	-0.13	-0.35	-0.38	-0.12	-0.4	0.63	0.14	-0.06	-0.35	-0.35	-0.43	-0.02	-0.14	-0.29		-0.11	-0.39	-0.19	-0.13	-0.24	-0.46	-0.23	-0.35	-0.32	0.08
Non Current Liabilities Total	-0.27	0.84	-0.29	-0.15	-0.1	-0.35	0.06	0.67	0.17	-0.18	-0.2	-0.07	-0.27	0.83	-0.72	-0.11		0.41	-0.18	-0.39	-0.04	-0.38	0.78	-0.17	0.62	-0.78
Inventory	0.39	0.65	0.52	0.68	0.59	-0.59	-0.77	0.72	0.77	0.71	-0.46	0.48	-0.64	0.7	-0.24	-0.39	0.41		0.31	-0.18	0.55	0.28	0.78	0.72	0.94	-0.45
Other Current Assets	0.13	-0.12	0.24	0.36	0.31	-0.32	-0.3	0.07	0.39	0.51	-0.22	-0.01	-0.31	-0.15	0.03	-0.19	-0.18	0.31		-0.06	0.2	0.22	-0.08	0.49	0.2	0.15
Other Stockholder Equity	0.04	-0.23	0.13	-0.07	0.46	0.5	-0.2	-0.28	-0.52	-0.11	0.09	0.01	0.07	-0.24	0.45	-0.13	-0.39	-0.18	-0.06		-0.17	0.06	-0.16	-0.12	-0.18	0.12
Total Liab	0.76	0.11	0.88	0.9	0.59	-0.38	-0.37	0.35	0.75	0.83	-0.41	0.86	-0.53	0.03	-0.09	-0.24	-0.04	0.55	0.2	-0.17		0.61	0.1	0.82	0.43	0.35
Total Current Assets	0.96	-0.22	0.78	0.7	0.29	0.19	-0.47	-0.31	0.38	0.63	0.31	0.8	0.17	-0.16	0.42	-0.46	-0.38	0.28	0.22	0.06	0.61		-0.12	0.61	0.19	0.44
Intangible Assets	-0.03	0.94	0.02	0.14	0.24	-0.44	-0.49	0.77	0.35	0.14	-0.26	0.1	-0.37	0.99	-0.44	-0.23	0.78	0.78	-0.08	-0.16	0.1	-0.12		0.14	0.9	-0.88
Common Stock	0.69	0.0	0.86	0.96	0.7	-0.45	-0.64	0.31	0.85	0.99	-0.46	0.73	-0.63	0.03	0.08	-0.35	-0.17	0.72	0.49	-0.12	0.82	0.61	0.14		0.51	0.29
Net Receivables	0.29	0.82	0.37	0.51	0.5	-0.56	-0.63	0.78	0.65	0.51	-0.39	0.39	-0.54	0.85	-0.39	-0.32	0.62	0.94	0.2	-0.18	0.43	0.19	0.9	0.51		-0.63
Non Currrent Assets Other	0.43	-0.88	0.43	0.32	0.09	0.27	0.24	-0.6	0.03	0.29	0.07	0.35	0.11	-0.91	0.44	0.08	-0.78	-0.45	0.15	0.12	0.35	0.44	-0.88	0.29	-0.63

Click cells to compare fundamentals

Adicet Bio Account Relationship Matchups

Adicet Bio fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	81.6M	153.8M	338.9M	330.7M	207.3M	215.3M
Short Long Term Debt Total	114.1M	21.6M	20.9M	21.0M	20.9M	19.9M
Other Current Liab	2.8M	(2.8M)	6.7M	12.8M	13.4M	18.3M
Total Current Liabilities	14.9M	14.0M	16.3M	19.7M	19.3M	18.3M
Total Stockholder Equity	(60.4M)	(106.3M)	(168.3M)	(238.1M)	170.2M	178.7M
Property Plant And Equipment Net	2.1M	25.9M	35.0M	49.0M	44.2M	46.4M
Net Debt	103.5M	(62.7M)	(256.6M)	(236.6M)	(138.8M)	(131.8M)
Retained Earnings	(69.6M)	(106.3M)	(168.3M)	(238.1M)	(380.8M)	(361.7M)
Accounts Payable	1.1M	1.6M	3.3M	4.4M	2.6M	2.5M
Cash	10.6M	84.3M	277.5M	257.7M	159.7M	83.6M
Non Current Assets Total	17.4M	59.2M	56.5M	69.7M	45.0M	58.4M
Cash And Short Term Investments	62.4M	94.6M	277.5M	257.7M	159.7M	95.6M
Common Stock Shares Outstanding	2.1M	7.3M	31.0M	41.1M	43.0M	24.8M
Liabilities And Stockholders Equity	81.6M	153.8M	(132.5M)	(199.8M)	207.3M	165.2M
Non Current Liabilities Total	127.1M	246.2M	19.5M	18.6M	17.8M	16.9M
Other Current Assets	179K	363K	2K	380K	2.6M	2.4M
Other Stockholder Equity	137.6M	(106.7M)	(153.9M)	(4K)	550.9M	578.5M
Total Liab	142.0M	44.0M	35.8M	38.4M	37.1M	35.3M
Total Current Assets	64.2M	94.6M	282.4M	261.0M	162.3M	156.9M
Accumulated Other Comprehensive Income	(5.1M)	(41K)	23K	24K	(338.9M)	0.0
Common Stock	1K	3K	4K	2K	3.6K	3.4K
Non Currrent Assets Other	4.7M	12.1M	2.0M	1.2M	822.0K	863.1K

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Adicet Bio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Adicet Bio's short interest history, or implied volatility extrapolated from Adicet Bio options trading.

Pair Trading with Adicet Bio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Adicet Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adicet Bio will appreciate offsetting losses from the drop in the long position's value.

Moving together with Adicet Stock

0.91	TFX	Teleflex Incorporated Earnings Call This Week	Pair Corr
0.63	DVAX	Dynavax Technologies Financial Report 7th of May 2024	Pair Corr

Moving against Adicet Stock

0.51	FLGC	Flora Growth Corp Financial Report 20th of May 2024	Pair Corr
0.51	BHC	Bausch Health Companies Financial Report 2nd of May 2024	Pair Corr
0.43	DRRX	Durect Earnings Call This Week	Pair Corr
0.41	ACB	Aurora Cannabis Sell-off Trend	Pair Corr

The ability to find closely correlated positions to Adicet Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Adicet Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Adicet Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Adicet Bio to buy it.

The correlation of Adicet Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Adicet Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Adicet Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Adicet Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Adicet Bio is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Adicet Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Adicet Bio Stock. Highlighted below are key reports to facilitate an investment decision about Adicet Bio Stock:

How To Invest In Adicet

Details

Is Adicet Stock a good investment?

Details

What is Adicet Bio's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adicet Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

For more information on how to buy Adicet Stock please use our How to Invest in Adicet Bio guide.

Note that the Adicet Bio information on this page should be used as a complementary analysis to other Adicet Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for Adicet Stock analysis

When running Adicet Bio's price analysis, check to measure Adicet Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adicet Bio is operating at the current time. Most of Adicet Bio's value examination focuses on studying past and present price action to predict the probability of Adicet Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adicet Bio's price. Additionally, you may evaluate how the addition of Adicet Bio to your portfolios can decrease your overall portfolio volatility.

	Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Bonds Directory Find actively traded corporate debentures issued by US companies
	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
	Volatility Analysis Get historical volatility and risk analysis based on latest market data
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities
	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing

Is Adicet Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adicet Bio. If investors know Adicet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adicet Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(3.31)

Quarterly Revenue Growth

(1.00)

Return On Assets

(0.31)

Return On Equity

(0.62)

The market value of Adicet Bio is measured differently than its book value, which is the value of Adicet that is recorded on the company's balance sheet. Investors also form their own opinion of Adicet Bio's value that differs from its market value or its book value, called intrinsic value, which is Adicet Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adicet Bio's market value can be influenced by many factors that don't directly affect Adicet Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Adicet Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Adicet Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adicet Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Adicet Net Debt vs Total Liab Analysis

Net Debt vs Total Liab

Net Debt vs Total Liab Correlation Analysis

Correlation Coefficient

Net Debt

Total Liab

Adicet Bio fundamental ratios Correlations

Adicet Bio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Adicet Bio fundamental ratios Accounts

Pair Trading with Adicet Bio

Moving together with Adicet Stock

Moving against Adicet Stock

Complementary Tools for Adicet Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock	+ 0.99	Accounts Payable
Intangible Assets	+ 0.99	Good Will
Accounts Payable	+ 0.97	Total Current Liabilities
Total Current Assets	+ 0.96	Total Assets
Good Will	+ 0.96	Short Long Term Debt Total
Common Stock	+ 0.96	Total Current Liabilities

Non Currrent Assets Other	- 0.91	Good Will
Non Currrent Assets Other	- 0.88	Intangible Assets
Non Currrent Assets Other	- 0.88	Short Long Term Debt Total
Net Debt	- 0.82	Property Plant And Equipment Net
Non Currrent Assets Other	- 0.78	Non Current Liabilities Total
Cash And Short Term Investments	- 0.78	Net Debt